LEADER 01656nmm a2200409 u 4500
001 EB001896978
003 EBX01000000000000001059983
005 00000000000000.0
007 cr|||||||||||||||||||||
008 200523 ||| eng
100 1 |a Klenerman, Paul 
245 0 0 |a The immune system response to the SARS-COV-2 virus  |h Elektronische Ressource  |c Paul Klenerman 
260 |a London  |b Henry Stewart Talks  |c 2020, 2020 
300 |a 1 streaming audio file (17 min.)) 
505 0 |a Current knowledge on the immune response to SARS-COV-2 -- How the response to the novel virus is being studied -- The possibility of future health issues in infected individuals -- Future steps in the research into a COVID-19 infection 
653 |a COVID-19 
653 |a Patient Safety 
653 |a severe acute respiratory syndrome coronavirus 2 
653 |a Vaccination 
653 |a Coronavirus infections / Diagnosis 
653 |a Immunity 
653 |a Immune system 
653 |a Coronavirus infections / Immunological aspects 
653 |a Drug Design 
653 |a Vaccines / Development 
653 |a Coronavirus Infections / immunology 
653 |a Betacoronavirus / immunology 
653 |a Viral Vaccines 
653 |a Models, Animal 
653 |a Coronavirus Infections / diagnosis 
653 |a Immune System Phenomena 
041 0 7 |a eng  |2 ISO 639-2 
989 |b HST  |a Henry Stewart Talks 
490 0 |a The biomedical & life sciences collection 
500 |a Audio interview. - Title from title frames. - Mode of access: World Wide Web 
856 4 0 |u https://hstalks.com/bs/4218  |x Verlag  |z Streaming video file 
082 0 |a 570